Artificial Intelligence (AI) can Detect Low-Glucose Levels via ECG without Fingerpick Test

A new technology for detecting low glucose levels via ECG using a non-invasive wearable sensor, which with the latest Artificial Intelligence can detect hypoglycaemic events from raw ECG signals has been made by researchers from the University of Warwick.

Currently Continuous Glucose Monitors (CGM) are available by the NHS for hypoglycaemia detection (sugar levels into blood or derma). They measure glucose in interstitial fluid using an invasive sensor with a little needle, which sends alarms and data to a display device. In many cases, they require calibration twice a day with invasive finger-prick blood glucose level tests.

However, Dr Leandro Pecchia's team at the University of Warwick have today, the 13th January 2020 published results in a paper titled 'Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG' in the Nature Springer journal Scientific Reports proving that using the latest findings of Artificial Intelligence (i.e., deep learning), they can detect hypoglycaemic events from raw ECG signals acquired with off-the-shelf non-invasive wearable sensors.

Two pilot studies with healthy volunteers found the average sensitivity and specificity approximately 82% for hypoglycaemia detection, which is comparable with the current CGM performance, although non-invasive.

Dr Leandro Pecchia from the School of Engineering at the University of Warwick comments: "Fingerpicks are never pleasant and in some circumstances are particularly cumbersome. Taking fingerpick during the night certainly is unpleasant, especially for patients in paediatric age.

"Our innovation consisted in using artificial intelligence for automatic detecting hypoglycaemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping."

The figure shows the output of the algorithms over the time: the green line represents normal glucose levels, while the red line represents the low glucose levels. The horizontal line represents the 4mmol/L glucose value, which is considered the significant threshold for hypoglycaemic events. The grey area surrounding the continuous line reflects the measurement error bar.

The Warwick model highlights how the ECG changes in each subject during a hypoglycaemic event. The figure below is an exemplar. The solid lines represent the average heartbeats for two different subjects when the glucose level is normal (green line) or low (red line). The red and green shadows represent the standard deviation of the heartbeats around the mean. A comparison highlights that these two subjects have different ECG waveform changes during hypo events. In particular, Subject 1 presents a visibly longer QT interval during hypo, while the subject 2 does not.

The vertical bars represent the relative importance of each ECG wave in determining if a heartbeat is classified as hypo or normal.

From these bars, a trained clinician sees that for Subject 1, the T-wave displacement influences classification, reflecting that when the subject is in hypo, the repolarisation of the ventricles is slower.

In Subject 2, the most important components of the ECG are the P-wave and the rising of the T-wave, suggesting that when this subject is in hypo, the depolarisation of the atria and the threshold for ventricular activation are particularly affected. This could influence subsequent clinical interventions.

This result is possible because the Warwick AI model is trained with each subject's own data. Intersubjective differences are so significant, that training the system using cohort data would not give the same results. Likewise, personalised therapy based on our system could be more effective than current approaches.

Dr Leandro Pecchia comments: "The differences highlighted above could explain why previous studies using ECG to detect hypoglycaemic events failed. The performance of AI algorithms trained over cohort ECG-data would be hindered by these inter-subject differences.

"Our approach enable personalised tuning of detection algorithms and emphasize how hypoglycaemic events affect ECG in individuals. Basing on this information, clinicians can adapt the therapy to each individual. Clearly more clinical research is required to confirm these results in wider populations. This is why we are looking for partners."

Mihaela Porumb, Saverio Stranges, Antonio Pescapè, Leandro Pecchia.
Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG.
Sci Rep 10, 170, 2020. doi: 10.1038/s41598-019-56927-5.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...